天臣医疗涨2.02%，成交额2024.00万元，主力资金净流出148.52万元

Group 1 - The core viewpoint of the news is that Tianchen Medical has experienced significant stock price fluctuations and financial growth, with a notable increase in revenue and net profit year-on-year [1][2]. Group 2 - As of October 31, Tianchen Medical's stock price rose by 2.02% to 51.51 CNY per share, with a market capitalization of 4.18 billion CNY [1]. - The company has seen a year-to-date stock price increase of 219.28%, but has experienced a decline of 7.46% in the last five trading days and 13.05% in the last twenty days [1]. - Tianchen Medical's main business involves the research, innovation, and production of high-end surgical staplers, with 77.92% of revenue coming from non-powered products and 22.08% from powered products [1]. - As of September 30, the number of shareholders increased by 11.48% to 4,624, while the average circulating shares per person decreased by 10.29% to 17,550 shares [2]. - For the period from January to September 2025, Tianchen Medical achieved a revenue of 244 million CNY, representing a year-on-year growth of 20.66%, and a net profit of 71.95 million CNY, up 68.29% year-on-year [2]. - The company has distributed a total of 211 million CNY in dividends since its A-share listing, with 179 million CNY distributed over the past three years [2].